All articles by Kavya Chivukula

Kavya Chivukula

Sight Diagnostics raises $71m to boost commercial operations

Israeli diagnostics company Sight Diagnostics has raised $71m in a Series D funding round to commercialise the global launch of finger-prick complete blood count (CBC) analyser.

Sensus Healthcare acquires mobile aesthetic laser companies in Florida

US-based Sensus Healthcare has acquired mobile aesthetic laser companies Aesthetic Mobile Laser Services and Aesthetic Laser Partners in Florida, US.

Presidio Medical raises $30m to develop neuromodulation platform

US-based medical device company Presidio Medical has raised $30m in a funding round led by Invus Opportunities.

Cardiva Medical raises funds to commercialise vascular closure systems

American medical device company Cardiva Medical has completed a $45m equity financing round to support the continued commercial expansion of its vascular closure systems.

HOYA and Hitachi sign contract for endoscopic ultrasound systems

Japanese companies HOYA and Hitachi have entered a long-term technical collaboration and supply agreement for endoscopic ultrasound systems (EUS).

FDA clears Abbott’s Gallant devices for cardiac arrhythmia

Abbott has received the US Food and Drug Administration (FDA) approval for its Gallant implantable cardioverter-defibrillator (ICD) and cardiac resynchronisation therapy defibrillator (CRT-D) devices.

Vapotherm to expand nasal cannula production in response to Covid-19

Vapotherm is set to scale up capital equipment manufacturing capabilities to increase the production of its Precision Flow systems.

2019 top news stories

Brain-computer interface could translate thoughts into speech and US regulator sought additional details on $4.2bn Boston Scientific-BTG deal. wraps up key headlines from 2019.

Royal Philips receives FDA approval for drug-coated balloons

The US Food and Drug Administration (FDA) has approved two variants of Royal Philips’ 200mm and 150mm Stellarex 0.035” low-dose drug-coated balloons (DCB).

September’s top news stories

World-first cardio trial showed reduced wait times and hospital admissions and Orchestra gets CE-Mark for Moderato system to treat hypertension. wraps up key headlines from September 2019.